(Q38095569)

28 August 2017

title

Phosphoinositide 3-kinase and INPP4B in human breast cancer (English)

1 reference

28 August 2017

1 reference

Christina A. Mitchell

object named as

Christina A Mitchell

series ordinal

2

0 references

author name string

Micka C Bertucci

series ordinal

1

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

Annals of the New York Academy of Sciences

28 August 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 August 2017

volume

1280

1 reference

28 August 2017

page(s)

1-5

1 reference

PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Targeting the phosphoinositide 3-kinase pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Subtle variations in Pten dose determine cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

A null mutation in inositol polyphosphate 4-phosphatase type I causes selective neuronal loss in weeble mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12036

21 January 2018

Identifiers

DOI

10.1111/NYAS.12036

1 reference

28 August 2017

1 reference